Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lucas Richie

Sports Medicine Lebanon, TN Medical Doctor

NPI 1447419577 CMS profile 19938

100 Physicians Way, Suite 110, Lebanon, TN 37090

Open in the dashboard

General payments

$159,087

353 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lucas Richie of Lebanon, TN is reported in the CMS Open Payments database as having received $159,087 across 353 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $45,070 76
2024 General $51,006 85
2023 General $33,980 82
2022 General $19,388 55
2021 General $4,581 25
2020 General $1,012 10
2019 General $4,052 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lucas Richie
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Lucas Richie were reported at $45,070. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Lucas Richie Sports Medicine median Middle half National median
2019 $4,052 $1,176 $199–$4,249 $163
2020 $1,012 $708 $96–$2,890 $114
2021 $4,581 $1,213 $152–$3,994 $132
2022 $19,388 $1,230 $159–$3,998 $149
2023 $33,980 $584 $146–$2,836 $160
2024 $51,006 $628 $163–$3,168 $164
2025 $45,070 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $142,097 236 payments
  2. Arthrex, Inc. $6,469 44 payments
  3. Alpha Orthopedic Systems $6,263 19 payments
  4. TriMed, Inc. $1,684 2 payments
  5. Electronic Waveform Lab, Inc. $713 4 payments
  6. Stryker Corporation $552 9 payments
  7. Music City Medical Technologies, LLC $335 6 payments
  8. Miach Orthopaedics, Inc. $214 1 payment
  9. NuVasive Specialized Orthopedics, Inc. $159 1 payment
  10. CyMedica Orthopedics, Inc. $98 1 payment
  11. Other $504 30 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $92,175 45 payments
  2. Travel and Lodging $34,596 114 payments
  3. Consulting Fee $14,700 4 payments
  4. Food and Beverage $11,521 183 payments
  5. Education $6,096 7 payments
Products named General payments · program years 2019–2025
  1. Bioinductive Implant with Arthroscopic Delivery System - Medium $80,042 153 payments
  2. Bone Anchors with Arthroscopic Delivery System $69,097 82 payments
  3. HEALICOIL Sports Med Shoulder $9,959 14 payments
  4. HEALICOIL Sports Med Shoulder $4,893 7 payments
  5. SPATIAL FRAME $4,545 4 payments
  6. Q-FIX $1,088 9 payments
  7. Mini-Open Latarjet $1,033 8 payments
  8. ENDOBUTTON $1,033 8 payments
  9. ACUFEX Meniscal Root Repair $834 3 payments
  10. Coblation $626 4 payments
  11. Other $3,682 66 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

434

Median for Orthopedic Surgery: 203

Drug cost

$3,179

Median for Orthopedic Surgery: $1,433

Branded share of claims

13.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 25 $882
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 57 $798
Methylprednisolone Generic 67 $425
Meloxicam Generic 119 $305
Ondansetron Hcl Generic 71 $258
Mupirocin Generic 34 $248
Ibuprofen Generic 16 $210
Tramadol Hcl Generic 16 $27
Cephalexin Generic 29 $26

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$79,178

Of which drugs: $5,842

Medicare patients

183

Average age 74

Services billed

1,628

121 women, 62 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 64%
Depression 30%
Diabetes 28%
Chronic kidney disease 27%
Ischemic heart disease 26%
COPD 14%
Heart failure 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 47 113 $545

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

353 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record